medline.ch Urologie-Nephrologie

	Immunotherapy Rechallenge in Metastatic Renal Cell Carcinoma: A Meta-Analysis of Randomized Clinical Trials. Oncologist Bolek H, Yazgan SC, Yekedüz E, McGregor BA, McKay RR, Pal SK, Choueiri TK, Ürün Y. PMID: 41452751 [PubMed - as supplied by publisher]
	Corrigendum to: Advancing Veterinary Imaging: Insights and Future Directions for Renal Lymphangiectasia Diagnosis. Vet Radiol Ultrasound Qin Y, Zhuang D, Jin C. PMID: 41452293 [PubMed - in process]
	Impact of deep remission on renal flare in pure class V lupus nephritis: results from KEIO-SLE cohort, a retrospective cohort study. Mod Rheumatol Kawai M, Hanaoka H, Fukui H, Suzuki K, Hiramoto K, Takei H, Kikuchi J, Kaneko Y. PMID: 41452019 [PubMed - as supplied by publisher]
	Glomangioma of the Kidney: Report of a Rare Presentation and Comprehensive Review of the Literature. Int J Surg Pathol Alroaini H, Hussain B, Alruwaii FI, Gupta N, Rogers CG, Al-Obaidy KI. PMID: 41451932 [PubMed - as supplied by publisher]
	The First Clinical Renal Xenotransplantation Study (EXPAND): Evaluating Safety, Function, and Zoonotic Risks. Health Care Sci Nashan B. PMID: 41451389 [PubMed]
	Recent progress in pig-to-human kidney xenotransplantation. Front Immunol Tao P, Zhou K. PMID: 41451219 [PubMed - indexed for MEDLINE]
	Current perspectives and trends on the role of mitochondria in renal ischemia-reperfusion injury from 2005 to 2024: a bibliometric analysis and literature review. Front Physiol Yan R, Zhang Y, Li Z, Li K, Man J, Yang L. PMID: 41451126 [PubMed]
	HIF-2Î± inhibitors in clear cell renal cell carcinoma: a clinical pharmacy perspective on lipid metabolism, therapeutic management, and resistance strategies. Front Med (Lausanne) Chen D, Hua C. PMID: 41451091 [PubMed]
	Retraction: Out of Pocket Expenditure and Catastrophic Expenditure on Haemodialysis: A Cross Sectional Study on Patients with Chronic Kidney Disease in Palakkad, Kerala. Indian J Community Med PMID: 41451045 [PubMed]
	Sertoli cells as a hub in testicular development and male reproductive. Front Cell Dev Biol Feng X, Tian J, Han S, Wen F, Li Y, Zhang S, Ouyang L, Hu Z, Chen X, Hu J. PMID: 41450735 [PubMed]
	Correction: TET2 gene mutation status associated with poor prognosis of transition zone prostate cancer: a retrospective cohort study based on whole exome sequencing and machine learning models. Front Endocrinol (Lausanne) Wang Y, Yu A, Gao Z, Yuan X, Du X, Shi P, Guan H, Wen S, Wang H, Wang L, Fan B, Liu Z. PMID: 41450576 [PubMed - in process]
	Community Understanding and Attitudes Toward Prostate-Specific Antigen (PSA) Testing for Prostate Cancer Screening: A Cross-Sectional Survey Study From Saudi Arabia. Cureus Alkhars AF, Almaghlouth AK, Almusalem NF, Alaboud MS, Alshafei AB, Al Janobi MS, Al Watyan HA, Alramadhan HM, Alramadhan HA. PMID: 41450362 [PubMed]
	Canine prostatic-specific esterase and prostatic ultrasound correlation in dogs: diagnostic value, influence of castration and clinical cut-off proposal. J Small Anim Pract Rodríguez-Trujillo R, Batista-Arteaga M, Iusupova K. PMID: 41450286 [PubMed - as supplied by publisher]
	Clinical efficacy of apalutamide in Asian patients with metastatic castration-sensitive prostate cancer: Bayesian reanalysis of the TITAN trial. Jpn J Clin Oncol Chen W, Yoshida S, Hirakawa A, Sato H, Yajima S, Kobayashi M, Fujiwara M, Fukushima H, Arita Y, Waseda Y, Tanaka H, Masuda H, Fujii Y. PMID: 41450247 [PubMed - as supplied by publisher]
	Predictive Factors for Gastrointestinal and Hepatic Adverse Events During 5-Aminolevulinic Acid-Guided Photodynamic Diagnosis in Bladder Cancer: Exploratory Analysis of the Phase III SPP2C102 Trial. Int J Urol Taoka R, Fukuhara H, Miyake M, Kobayashi K, Ikeda A, Kanao K, Komai Y, Fujiwara R, Sato Y, Sugimoto M, Tsuzuki T, Fujimoto K, Inoue K, Oya M. PMID: 41449791 [PubMed - as supplied by publisher]
	Putative Tissue-Based Biomarkers of Male Genital Lichen Sclerosus-A Systematic Literature Review. Australas J Dermatol Desai D, Reinke A, Stehr E, Whiteside EJ, De Win G, Windus LCE. PMID: 41449678 [PubMed - as supplied by publisher]
	Real-world efficacy of switching androgen receptor signaling inhibitor therapy following apalutamide discontinuation because of adverse events in advanced prostate cancer: a multicenter study. Jpn J Clin Oncol Tohi Y, Kato T, Fujiwara K, Hayashida Y, Matsuoka Y, Hirama H, Yano T, Tsunemori H, Arai H, Nomura I, Yamaoka N, Mashima T, Kohashiguchi K, Abe Y, Naito H, Okazoe H, Taoka R, Ueda N, Sugimoto M. PMID: 41449570 [PubMed - as supplied by publisher]
	Decision support training for chronic kidney disease dyads: the ImPart Study protocol. Pilot Feasibility Stud Gazaway S, Wells R, Gutierrez OM, Azuero A, Cole A, Nix-Parker T, Pitts L, Lyas C, Lang-Lindsey K, Knight R, Pazant P, Gustafuson N, Rayburn A, Umeukeje E, Odom JN. PMID: 41449447 [PubMed - as supplied by publisher]
	CKD-M2 study: 2-year mortality prediction tool for advanced kidney disease. BMC Nephrol Tran DNT, Dimitrov Y, Chantrel F, Perrin P, Tubail Z, Fouque D, Ducher M, Fauvel JP. PMID: 41449356 [PubMed - as supplied by publisher]
	Evaluation of INR101, a PSMA-Targeted (18)F PET Tracer, for suspected prostate cancer: A multicenter phase I/IIa trial with histopathologic confirmation. EJNMMI Res Yang J, Wan W, Zhang J, Zhang N, Yang X, Wang W, Ma H, Xu Y, Fu Z, Wang X, Liu Y, Wang M, Liu F, Guo Y, Liu Y, Zhang X. PMID: 41449298 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 462627

Seite 1 von 23132

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung